Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection
NCT ID: NCT06531460
Last Updated: 2024-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
310 participants
INTERVENTIONAL
2024-07-25
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay
NCT01789073
Oral Immunonutrition With Synbiotics, Omega 3 and Vitamin D in Patients Undergoing Duodenopancreatectomy for Tumoral Lesion.
NCT05271344
Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer
NCT02321202
Perioperative Supplementation With Immunonutrition and Its Impact on Surgical Outcome and Pain in Oral Cavity or Mandibular Tumours
NCT06339372
PeRioperative Omega Three and the Effect on ImmuNity
NCT03598413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental enteral nutrition
Patients admitted to the hospital at least three days before surgery Use of an enteral feeding tube to administer enriched enteral formula
Fish oil enteral supplementation
Omega-3 (4.2 g), administered through an enteral feeding tube, three days before surgery
Experimental oral nutrition
Patients admitted one day before surgery. Home-self administration of enriched enteral formula three days before surgery
Fish oil oral supplementation
Omega-3 (4.2 g), orally administered enriched nutritional formula, drinking at home three days before surgery
Standard enteral nutrition
Patients admitted to the hospital at least three days before surgery Use of an enteral feeding tube to administer standard enteral formula
Enteral nutrition without fish oil
Enteral formula without omega-3 administered through an enteral feeding tube, three days before surgery
Standard oral nutrition
Patients admitted one day before surgery. Home-self administration of standard enteral formula three days before surgery
Oral nutritional supplement without fish oil
Oral nutritional supplement without omega-3 orally administered, drinking at home three days before surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fish oil enteral supplementation
Omega-3 (4.2 g), administered through an enteral feeding tube, three days before surgery
Fish oil oral supplementation
Omega-3 (4.2 g), orally administered enriched nutritional formula, drinking at home three days before surgery
Enteral nutrition without fish oil
Enteral formula without omega-3 administered through an enteral feeding tube, three days before surgery
Oral nutritional supplement without fish oil
Oral nutritional supplement without omega-3 orally administered, drinking at home three days before surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective surgery for lung resection schedule at least four days before surgery
* Signed informed consent.
Exclusion Criteria
* Patients with fish-allergy
* History of any surgery within 3 months
* Immunocompromised patients
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Respiratory Diseases, Mexico
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ivan Armando Osuna Padilla
Clinical Nutrition Manager
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ivan A Osuna-Padilla, PhD
Role: PRINCIPAL_INVESTIGATOR
Instituto Nacional de Enfermedades Respiratorias
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Respiratory Diseases
Mexico City, , Mexico
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C34-24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.